Prostate-specific membrane antigen expression in normal and malignant human tissues

Clinical Cancer Research

Volumn 3, Issue 1, 1997, Pages 81-85

  Silver, David A ^a   Pellicer, Inmaculada ^a   Fair, William R ^a   Heston, Warren D W ^a   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLADDER CANCER; CELL DIFFERENTIATION; COLON CARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATIC NEOPLASMS; TISSUE DISTRIBUTION;

EID: 0031042591     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Abdel-Nabi, H., Wright, G. L., Gulfo, J. V., Petrylak, D. P., Neal, C. E., Texter, J. E., Begun, F. P., Tyson, I., Heal, A., Mitchell, E., Pumell, G., and Harwood, S. J. Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer. Semin. Urol., 10: 45-54, 1992.
2. Israeli, R. S., Powell, C. T., Fair, W. R., and Heston, W. D. W. Molecular cloning of a complementary DNA encoding a prostate- specific membrane antigen. Cancer Res., 53: 227-230, 1993.
3. Carter, R. E., Feldman, A. R., and Coyle, J. T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc, Natl. Acad. Sci. USA, 93: 749-753, 1996.
4. Rinker-Schaeffer, C. W., Hawkins, A. L., Su, S. L., Israeli, R. S., Griffin, C. A., Isaacs, J. T., and Heston, W. D. W. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics, 30: 105-108, 1995.
5. Leek, J., Lench, N., Maraj, B., Bailey, A., Carr, I. M., Andersen, S., Cross, J., Whelan, P., MacLennan, K. A., Meredith, D. M., and Markham, A. F. Prostate-specific membrane antigen: evidence for the existence of a second related human gene. Br. J. Cancer, 72: 583-588, 1995.
6. Su, S. L., Huang, I-P., Fair, W. R., Powell, C. T., and Heston, W. D. W. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441-1443, 1995.
7. Horoszewicz, J. S., Kawinski, E., and Murphy, G. P. Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients. Anticancer Res., 7: 927-936, 1987.
8. Lopes, A. D., Davis, W. L., Rosenstraus, M. J., Uveges, A. J., and Gilman, S. C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res., 50: 6423-6429, 1990.
9. Wright, G. L., Jr., Haley, C., Beckett, M. L., and Schellhammer, P. F. Expression of prostate-specific membrane antigen in normal, benign and malignant prostate tissues. Urol. Oncol., I: 18-28, 1995.
10. Sanford, E., Grzonka, R., Heal, A., Helal, M., Persky, L., and Tyson, I. Prostate cancer imaging with a new monoclonal antibody: a preliminary report. Ann. Surg. Oncol., 1: 400-404, 1994.
11. 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence. J. Urol., 152: 1490-1495, 1994.
12. 111indium-labeled monoclonal antibody CYT- 356. J. Urol., 152: 1952-1955, 1994.
13. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R., and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
14. Troyer, J. K., Beckett, M. L., and Wright, G. L., Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int. J. Cancer, 62: 552-558, 1995.
15. Pinto, J., Suffoletto, B., Berzin, T., Qaio, C., Lin, S., Tong, W., and Heston, W. D. W. Identification of a membrane-bound pteroyl poly gamma-glutamyl carboxypeptidase (folate hydrolase) that is highly expressed in human prostatic carcinoma cells (Abstract 2862). FASEB J., 10: A496, 1996.
16. Thalmann, G. N., Ploutarchos, E. A., Chang, S-M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. K. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res., 54: 2577-2581, 1994.